Homepage
Open in app
Sign inGet started

Spero Ventures

News, podcasts, and insights from Spero Ventures.

  • Partner Perspectives
  • Founder Resources
  • Product Leadership
  • Spero in Dialogue

    Spero in Dialogue

    5/19–5/23
    Go to the profile of Nolan Shah
    Nolan Shah
    May 24
    Why We Invested in Persist AI: Formulating Drugs Better, Faster & Cheaper

    Why We Invested in Persist AI: Formulating Drugs Better, Faster & Cheaper

    In the summer of 2012, the FDA approved the first pre-exposure pill for HIV. The drug promised to reduce the risk of contracting HIV, but…
    Go to the profile of Sara Eshelman
    Sara Eshelman
    May 19
    Spero in Dialogue

    Spero in Dialogue

    5/12–5/16
    Go to the profile of Nolan Shah
    Nolan Shah
    May 16
    Spero in Dialogue

    Spero in Dialogue

    4/28–5/2
    Go to the profile of Nolan Shah
    Nolan Shah
    May 2
    Spero in Dialogue

    Spero in Dialogue

    4/21–4/25
    Go to the profile of Nolan Shah
    Nolan Shah
    Apr 25
    Spero in Dialogue

    Spero in Dialogue

    4/14–4/18
    Go to the profile of Nolan Shah
    Nolan Shah
    Apr 18
    Spero in Dialogue

    Spero in Dialogue

    4/7–4/11
    Go to the profile of Nolan Shah
    Nolan Shah
    Apr 11
    About Spero VenturesLatest StoriesArchiveAbout MediumTermsPrivacyTeams